Lemonade Inc (LMND)
Official siteFINANCIAL SERVICES • INSURANCE - PROPERTY & CASUALTY • NYSE
Market Cap: $3.44B
Last updated: Nov 17, 2026 at 11:06 AM ET
Lemonade Inc (LMND) Stock Forecast
Analysts expect Lemonade (LMND) to earn -$1.85 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.24B. Of 11 analysts, 3 rate the stock Buy or Strong Buy, 6 Hold and 2 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 4 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 11 ratings average 2.82, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 27% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 9.1% |
| Buy | 2 | 18.2% |
| Hold | 6 | 54.5% |
| Sell | 2 | 18.2% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 11
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 34.7%.
- Fiscal year ending Dec 31, 2026
- -$1.85
- EPS consensus, revenue $1.24B
- Fiscal year ending Dec 31, 2027
- -$1.04
- EPS consensus, revenue $1.67B
- Next report
- Feb 17, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$1.85 | -$2.03 to -$1.79 | 11 | $1.24B | $1.23B to $1.25B | 10 |
| Dec 31, 2027 | -$1.04 | -$1.40 to -$0.58 | 11 | $1.67B | $1.63B to $1.75B | 11 |
Quarterly Estimates
The EPS consensus falls from -$0.24 for the quarter ending Dec 31, 2026 to -$0.28 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.24 | -$0.29 to -$0.20 | 14 | $353.13M | $337.02M to $368.15M | 12 |
| Mar 31, 2027 | -$0.28 | -$0.35 to -$0.17 | 8 | $377.61M | $367.00M to $396.00M | 8 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 11 upward and 2 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 4 | 0 |
| Fiscal year ending Dec 31, 2027 | 6 | 2 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$1.87.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.85 | -$1.85 | -$1.85 | -$1.87 | -$1.87 | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.04 | -$1.10 | -$1.10 | -$1.10 | -$1.07 | N/A |
| Quarter ending Mar 31, 2027 | -$0.28 | -$0.31 | -$0.31 | -$0.32 | -$0.31 | N/A |
Frequently Asked Questions About LMND
What is the LMND stock forecast?
Consensus analyst estimates put Lemonade's EPS at -$1.85 for the fiscal year ending Dec 31, 2026, on revenue of $1.24B. The consensus rating from 11 analysts is Hold.
How do analysts rate LMND stock?
Of 11 analysts covering Lemonade, 1 rates it Strong Buy, 2 Buy, 6 Hold, 2 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from LMND next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.85, with estimates from -$2.03 to -$1.79 from 11 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.04, with estimates from -$1.40 to -$0.58 from 11 analysts.
What revenue do analysts expect from Lemonade next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.24B, with estimates from $1.23B to $1.25B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.67B, with estimates from $1.63B to $1.75B.
How many analysts cover LMND?
11 analysts rate Lemonade stock, and 11 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
LMND pages: Overview, Earnings, Forecast, Financials, Competitors